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Keratinocyte-Specific Deletion of the Receptor RAGE
Modulates the Kinetics of Skin Inflammation In Vivo
Julia S. Leibold1, Astrid Riehl1, Jan Hettinger2, Michael Durben3, Jochen Hess4,5 and Peter Angel1
The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor causally related to the
pathogenesis of acute and chronic inflammation. In a mouse model of inflammation-driven skin carcinogenesis,
RAGE deletion conferred protection from the development of skin tumors due to a severely impaired cutaneous
inflammation. Although the impact of RAGE expression in immune cells was shown to be essential for the
maintenance of a cutaneous inflammatory reaction, the role of RAGE in keratinocytes remained unsolved. Using
mice harboring a keratinocyte-specific deletion of RAGE, we analyzed its role in the regulation of an acute
inflammatory response that was induced by topical treatment of the back skin with the phorbol ester
12-O-tetradecanoyl-phorbol-13-acetate (TPA). We show that RAGE expression in cutaneous keratinocytes
modulates the strength and kinetics of acute inflammation and supports the maintenance of epidermal
keratinocyte activation. To address the underlying molecular mechanism, we isolated interfollicular epidermis
by laser microdissection for gene expression analysis, and identified RAGE as a regulator in the temporal control
of TPA-induced epidermal tumor necrosis factor alpha transcript levels. In summary, our data demonstrate that
RAGE expression in keratinocytes is critically involved in the perpetuation of acute inflammation and support the
central role of RAGE in paracrine communication between keratinocytes and stromal immune cells.
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INTRODUCTION
The receptor for advanced glycation end products (RAGE) has
been implicated in the development of various inflammatory
disorders such as rheumatoid arthritis, atherosclerosis, inflam-
matory bowel disease, and cancer (Chavakis et al., 2004;
Alexiou et al., 2010). The role of RAGE in inflammation-
associated carcinogenesis has been demonstrated using a
model of colitis-induced cancer (Turovskaya et al., 2008) and
in the mouse model of two-stage skin tumorigenesis (Gebhardt
et al., 2008). Rage / mice were protected from skin tumor
development as the inflammatory response after 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) administration, a
potent inducer of inflammation and tumor promoter, was
strongly diminished as compared with wild-type (wt) mice.
In order to elucidate the contribution of RAGE in immune cells
to cutaneous inflammation, bone marrow chimeras were
generated using Rage / and wt animals. Transfer of wt
bone marrow in Rage / animals resulted in the partial
rescue of cutaneous inflammation, determined as dermal
immune cell infiltration and epidermal hyperplasia (Gebhardt
et al., 2008). This suggested a central role of RAGE expression
in leukocytes for the maintenance of tumor-promoting
inflammation, whereas the functional impact of RAGE
expression in keratinocytes remained unsolved.
We used mice harboring a keratinocyte-specific deletion of
RAGE (RageDker) to analyze the impact of RAGE expression in
keratinocytes on the regulation of acute cutaneous inflamma-
tion. Our analyses revealed that TPA-induced skin inflamma-
tion and keratinocyte activation were not affected during the
initial phase, but were strongly reduced at later time points in
RageDker as compared with control animals. To address the
underlying molecular mechanism, we isolated interfollicular
epidermis by laser microdissection and analyzed gene expres-
sion of known mediators of inflammation. We detected a
temporal reduction of tumor necrosis factor alpha (TNF-a)
transcript levels in RageDker animals, suggesting that RAGE-
dependent TNF-a expression in keratinocytes is involved in
the perpetuation of skin inflammation.
RESULTS
Generation of a conditional mouse model with keratinocyte-
specific ablation of RAGE
Experiments with conventional Rage / animals revealed
that ubiquitous RAGE deletion leads to a strong impairment of
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acute as well as chronic inflammatory responses of the skin
(Gebhardt et al., 2008; Riehl et al., 2010). In order to analyze
the role of epidermal RAGE in the establishment and
maintenance of skin inflammation, we generated a
conditional mouse model with keratinocyte-specific ablation
of RAGE (RageDker). K14-Cre mice carrying a Cre transgene
under the control of the mouse Keratin 14 promoter (Huelsken
et al., 2001), which is active in basal keratinocytes, were bred
with Rageflx/flx mice carrying loxP sites adjacent to the
essential RAGE exons 2–7 in both alleles ((Liliensiek et al.,
2004); Figure 1a). Specific and efficient deletion of the floxed
alleles was confirmed by semiquantitative PCR with genomic
DNA (Figure 1b) and immunofluorescence staining for EGFP
transgene expression (Figure 1c–f), which is induced following
successful recombination of the floxed allele (described
in Liliensiek et al. (2004)). For the following experiments,
Rageflx/flx mice were used as control animals.
Kinetics of inflammation following a single TPA treatment of
back skin
Age-matched control and RageDker female mice were treated
with a single TPA stimulus, skin biopsies were taken at various
time points after treatment, and paraffin-embedded tissue
sections were analyzed by immunohistochemical staining for
the myeloid marker Gr-1. Gr-1þ cells were visible in the
dermis already at 6 hours after TPA treatment, whereas almost
no Gr-1þ cells were detectable in the skin of acetone-treated
mice (Figure 2). Interestingly, the number of Gr-1þ cells was
comparable for control and RageDker animals at 6, 12, and
24 hours after TPA treatment. However, 48 hours after treat-
ment, Gr-1þ cells reached basal levels in the dermis of most
RageDker animals, whereas a higher number still persisted in
TPA-treated control mice. Comparable results were obtained
by immunohistochemical study for S100a8 and S100a9
proteins, which are highly expressed in cells of the myeloid
lineage ((Hessian et al., 1993); Supplementary Figure S1
online and data not shown). In contrast, no difference was
observed for mast cells (determined by toluidine blue staining;
data not shown) and epidermal CD3þ cells (data not shown).
Quality and quantity of the immune cell infiltrate following a
single TPA stimulus of the back skin
Further, we used flow cytometry to precisely define and
quantify the kinetics of infiltration and persistence of total
leukocytes, and the subpopulations of neutrophils, monocytes,
and macrophages (Supplementary Figure S2 online). In line
with the immunohistochemical study, increasing numbers of
all immune cell subpopulations were detected at 6 and 12 hours
following TPA treatment for both control and RageDker, as
compared with acetone-treated animals (Figure 3). Interest-
ingly, 24 hours after TPA treatment, the median numbers for
all cell subpopulations except for macrophages were higher
in RageDker as compared with control animals, whereas, at
48 hours, RageDker animals showed a strong decrease in the
amount of all cell subpopulations, which was statistically
significant for total leukocytes, monocytes, and macrophages.
In the skin of TPA-treated controls, the number of neutrophils
was maintained up to 48 hours, whereas the quantity of
monocytes slightly decreased, and the amount of CD45þ
leukocytes and macrophages was further increased as com-
pared with 24 hours upon treatment (Figure 3).
In summary, our data demonstrate that the keratinocyte-
specific deletion of RAGE interferes with the temporal regula-
tion of a TPA-induced acute immune response and strongly
points to an earlier onset of a more efficient resolution phase
in the back skin of RageDker as compared with control animals.
Impact of keratinocyte-specific RAGE deletion on the epidermis
in response to single TPA treatment
Following a single TPA treatment, the thickness of the
epidermis was determined on tissue sections upon hematox-
ylin/eosin staining (Figure 4a). At 12 and 24 hours after TPA
treatment, the epidermal thickness was increased as compared
with both acetone-treated RageDker and control animals. At
48 hours after the TPA stimulus, however, RageDker animals
exhibited a significant reduction in the epidermal thickness
(P¼ 0.006) when compared with control animals, in which
increased epidermal thickness was maintained up to 48 hours.
This suggests that keratinocyte-specific deletion of RAGE
affects the kinetics of keratinocyte activation under the settings
of acute inflammation. This assumption was further supported
by immunofluorescence staining for the nonconventional
Keratin 6, an established marker for keratinocyte activation
(Mansbridge and Knapp, 1987; Molloy and Laskin, 1987;
Rothnagel et al., 1999). Although no Keratin 6 protein
K14-Crea
b
c d
e f
K14-Cre Rageflx/wt
K14-Cre Rageflx/flx
Rage
Sec. ab
Anti -G
FP
Junb
Ra
ge
flx/
flx
Rageflx/flx
Rageflx/flx
Rageflx/flx
= Rageker
Ra
ge
k
er
H 2
O
Rageker
Figure 1. Generation of RageDker mice and confirmation of keratinocyte-
specific receptor for advanced glycation end products (RAGE) deletion.
(a) Breeding scheme for the generation of RageDker mice. (b) Genomic DNA
was prepared from the tail epidermis of Rageflx/flx and RageDker mice. Equal
amounts of DNA were used for PCR analysis with Rage-specific primers and,
as a control for DNA quality and quantity, with Junb-specific primers. (c–f) Cre-
mediated recombination was monitored by immunofluorescence for epidermal
enhanced green fluorescent protein (EGFP) expression (red signal; nuclei were
stained with Hoechst H33342, blue signal). Rageflx/flx (c, e) and RageDker (d, f)
mice were treated three times with 10 nmol 12-O-tetradecanoyl-phorbol-13-
acetate (TPA) in 100ml acetone at an interval of 48 hours. Sections stained with
secondary antibody (Sec. ab) alone served as a control for antibody specificity
(c, d). GFP, green fluorescent protein. Scale bar¼ 100mm.
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expression was detected in the interfollicular epidermis of
acetone-treated animals and 6 hours following TPA treatment,
a continuous increase was found for both genotypes up to
24 hours upon TPA administration (Figure 4b–k). In line with
the data on epidermal thickness, control animals displayed a
further increase in Keratin 6 protein levels at 48 hours after
TPA treatment (Figure 4f), whereas no staining was detected in
the interfollicular epidermis of RageDker mice at this time point
(Figure 4k).
Impact of RAGE on the expression of proinflammatory mediators
in keratinocytes
So far, our data confirm that keratinocyte-specific RAGE
ablation modulates the kinetics of an acute response of the
skin upon TPA stimulation with the most prominent pheno-
type at 48 hours after treatment. We hypothesized that this
phenotype was causally related to RAGE-dependent expres-
sion of keratinocyte-derived mediators of inflammation. There-
fore, we analyzed epidermal gene expression at different time
points (12, 24, and 48 hours) after TPA treatment, as we
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Figure 3. Quantification of infiltrating immune cells following a single 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) treatment of back skin. Back skin of
control (gray boxes) and RageDker mice (empty boxes) was treated with 10 nmol
TPA in 100ml acetone (6, 12, 24, and 48 hours) or acetone only (Ac); animals
were killed at the indicated time points after treatment (more than three
animals per group and genotype; two animals for acetone treatment). Activated
infiltrating immune cells were isolated by enzymatic digestion and analyzed by
flow cytometry. The Mann–Whitney rank-sum test was used to calculate
statistical significance. (a) Leukocytes (*P¼ 0.017); (b) monocytes (*P¼ 0.017);
(c) macrophages (**P¼0.004); (d) neutrophil granulocytes (no statistically
significant difference).
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Figure 2. Gr-1þ immune cells infiltrate the dermis following a single 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) stimulus. The back skin of control
(a–e) and RageDker mice (f–j) was treated with 10 nmol TPA in 100ml acetone
(6, 12, 24, and 48 hours) or acetone only (Ac); the animals were killed at the
indicated time points after treatment. Activated immune cells infiltrating into
the dermis of the treated skin were detected by immunohistochemical
staining using anti-Gr-1 (red staining). Sections were counterstained with
hematoxylin (blue staining). Representative images of at least three animals per
genotype and time point are shown. Scale bar¼ 100mm.
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assumed that the underlying alterations preceded the RAGE-
dependent phenotype. We isolated interfollicular epidermis by
laser microdissection from tissue sections of back skin to
determine the expression of several candidate genes (Ccl6,
Ccl9, Ccl2 (MCP-1), Ccl3 (Mip1a), Cxcl1, Cxcl2, Cxcl10,
S100a8, S100a9, Il6, Il1a, Il1b, Il1rn, Il1r1, Il1r2, Tnf (TNF-a),
Tnfrsf1a, and Tnfrsf1b), which are implicated in the establish-
ment and resolution of an acute inflammation, by quantitative
real-time PCR (qRT–PCR). We found no significant difference
in the transcript levels for all tested genes with the exception
of TNF-a, for which we identified a severely reduced expres-
sion in TPA-treated epidermis of RageDker as compared with
control animals at 24 hours (Figure 5, Supplementary Figure
S3 online and data not shown). This did not result from
reduced induction of Tnf transcript levels depending on RAGE
deletion, as we detected comparable transcript levels at
12 hours after TPA administration (Supplementary Figure S3
online). Thus, our data suggest that the premature resolution of
skin inflammation in RageDker animals is at least in part due to
an earlier reduction in TNF-a expression by keratinocytes.
DISCUSSION
RAGE has been associated with the maintenance of inflamma-
tory conditions and perpetuated expression of proinflammatory
mediators. In experimental mouse models, the beneficial effect
of systemic RAGE inhibition by conventional gene deletion or
pharmacological inhibition has been studied (Ramasamy et al.,
2011). The only cell type–specific analysis of RAGE inhibition
so far describes the impact of RAGE deletion on immune cells,
which results in marked reduction of the inflammatory response
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Figure 4. Receptor for advanced glycation end products (RAGE) deletion
leads to earlier normalization of the epidermis after 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) treatment. Back skin of control (b–f) and RageDker
mice (g–k) was treated with 10 nmol TPA in 100ml acetone (6, 12, 24, and
48 hours) or acetone only (Ac); at least three animals per genotype were killed
at the indicated time points after treatment. (b–k) Keratin 6 expression was
detected by red immunofluorescence; nuclei were stained with Hoechst
H33342 (blue signal). Scale bar¼ 100mm. (a) Epidermal thickness was
measured from paraffin sections stained with hematoxylin and eosin; mean±
SD values are given in mm (two pictures per animal). Statistical significance
was determined using the Student’s t-test, *P¼0.006. Black bars¼ control
mice; empty bars¼RageDker mice.
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Figure 5. Transcript levels in the interfollicular epidermis 24hours after a
single 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulus. The back skin
of RageDker (n¼ 8) and control mice (n¼ 5) was treated with 10 nmol TPA and
animals were killed 24 hours after treatment. Interfollicular epidermis was
isolated from frozen tissue sections by laser microdissection and expression of
inflammatory genes (a: Il6; b: S100a8; c: Tnfrsf1a; d: Tnf) was analyzed by
quantitative real-time PCR (qRT–PCR). Boxes represent relative median
transcript levels and the 25th and 75th percentiles. The analysis revealed
receptor for advanced glycation end products (RAGE) dependency of transcript
levels only for Tnf (*P¼0.006; Mann–Whitney rank-sum test). NS, non
significant.
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(Gebhardt et al., 2008). However, studies on systemic RAGE
inhibition under inflammatory conditions disregard the fact that
many inflammatory factors, whose expression is controlled in a
RAGE-dependent manner, originate from multiple cell types
within a given tissue, e.g., keratinocytes, and immune cells of
the skin. In addition, the RAGE-dependent gene expression
analyzed in previous experiments was superimposed by cellular
changes, such as differential infiltration of the tissue by immune
cells. Consequently, most of the effects described so far may be
related to RAGE-dependent immune cell activation. In the
present approach, we have excluded the effect of RAGE in
immune cells, but specifically focused on the role of RAGE in
keratinocytes during the course of acute inflammation of the
skin. To this end, we used mice harboring a keratinocyte-
specific deletion of RAGE (RageDker) in a model of TPA-induced
acute skin inflammation and identified a, to our knowledge,
previously unreported function of RAGE in keratinocytes
regulating the kinetics of inflammation and inflammatory
gene expression.
Stimulation of the cutaneous inflammation by topical
application of TPA is a convenient model to analyze the
kinetics of acute skin inflammation, including the initiation
and resolution phase. As the inflammation in wt animals is
resolved within 72–96 hours (data not shown), one may
assume that only the innate immune system is involved and
an adaptive immune response is not yet elicited. This assump-
tion was confirmed by the immunohistochemical staining for
the T-cell marker CD3, showing no positive signals in the
dermis of TPA-treated skin up to 48 hours after treatment.
It has already been shown that RAGE is important for the
establishment and maintenance of an innate immune reaction
mediated by neutrophils, monocytes, and macrophages, and
that the lack of RAGE signaling in conventional Rage / mice
reduces dermal immune cell infiltration upon stimulation
(Gebhardt et al., 2008). However, our immunohistochemical
and flow cytometry analyses demonstrate that the keratinocyte-
specific deletion of RAGE also strongly influences the time
course of skin inflammation. In the induction phase of
inflammation, a slightly exaggerated immune cell infiltration
into the dermis was observed in RageDker animals. This finding
parallels the earlier observation that conventional Rage /
mice show a mild proinflammatory phenotype (Liliensiek et al.,
2004). In contrast, earlier resolution of inflammation in RageDker
animals at later time points suggests that the retention time of
the immune cells in the dermis was reduced in RageDker
animals as compared with controls, and hence immune
resolution was induced prematurely.
Similar to Rage / animals, RageDker mice exhibited an
impaired activation of keratinocytes at 48 hours as measured
by TPA-induced epidermal thickness and Keratin 6 expression,
which parallels the defect in the dermal inflammatory
response. In psoriasis, it has been shown that intradermal
injection of activated immune cells induces epidermal hyper-
plasia (Wrone-Smith and Nickoloff, 1996), implicating that
proinflammatory signals derived from immune cells change
epidermal homeostasis. Conversely, the overexpression of
RAGE ligands in keratinocytes primes mouse skin for
immune cell recruitment and a psoriasis-like phenotype
upon mechanical stress (Wolf et al., 2010). Experiments with
single and repeated TPA treatments of mouse back skin using
conventional Rage / animals revealed that both immune
cell recruitment and epidermal activation were strongly
impaired as compared with wt controls, so that cause and
consequence of the RAGE-dependent defect in both
compartments remained unclear. Our data demonstrate that,
at least under settings of acute inflammation mediated by a
single TPA stimulus, RAGE signaling in keratinocytes is not
only essential for the kinetics of a dermal immune response
but also influences epidermal homeostasis. However, because
of alterations in the quantity and quality of dermal leukocytes
in RageDker mice at the relevant time point in our mouse
model, it remains to be determined to which extent the
epidermal response was dependent on a keratinocyte-
intrinsic effect of RAGE or resulted from the RAGE-
dependent dermal inflammation.
TPA is well known to induce the expression of proinflam-
matory factors in keratinocytes, e.g., the key cytokine TNF-a,
whose deletion strongly impairs the cutaneous inflammatory
response to TPA in vivo (Moore et al., 1999). Recently, we
unraveled the kinetics of RAGE-dependent alterations in
global gene expression of mouse back skin following a
single TPA administration, which was characterized by an
early RAGE-independent phase and a late RAGE-dependent
phase (Riehl et al., 2010). It is worth noting that signaling and
gene regulatory networks, which are induced by TPA, may
simply compensate for the lack of RAGE in the initial phase of
acute inflammation. However, the maintenance of molecular
and cellular processes initiated by TPA was modulated by
RAGE expression at a later time point.
Our analysis of epidermal gene expression revealed that
TPA-induced transcription of many inflammatory mediators is
not changed, whereas transcript levels of TNF-a are reduced
earlier in the RageDker epidermis. We also demonstrated that
RAGE expression in normal keratinocytes is not essential for
the TPA-mediated induction but for the maintenance of
epidermal TNF-a transcript levels in vivo.
Under stress conditions, the inflammatory mediator TNF-a is
produced by a variety of different cell types (Vassalli, 1992). It
has been shown that RAGE signaling induces TNF-a expression
in monocytes, macrophages, microglia, and mesangial cells
(Miyata et al., 1996; Bianchi et al., 2010; Liang et al., 2010). On
the contrary, sequestering of RAGE ligands by the decoy
receptor sRAGE reduced TNF-a induction in vitro (Miyata
et al., 1996) and tissue levels of TNF-a in vivo (Hofmann
et al., 1999; Chen et al., 2004). In addition, TNF-a has been
shown to induce the expression of RAGE through nuclear factor-
kappa B activation (Tanaka et al., 2000; Mukherjee et al., 2005;
Frommhold et al., 2011). Most likely, this reciprocal regulation
is a part of the proposed proinflammatory feed-forward loop
preceding the establishment of chronic inflammation.
TNF-a has been shown to influence central events in the
onset of immune resolution, such as the occurrence of
apoptotic neutrophils and their removal by efferocytosis of
macrophages (Soehnlein and Lindbom, 2010). Inefficient
removal of apoptotic cells may lead to secondary necrosis,
thereby leading to the release of intracellular proteins acting as
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damage-associated molecular patterns. Interestingly, TNF-a
inhibits efferocytosis in macrophages through production of
reactive oxygen species, which are generated upon damage-
associated molecular pattern-activated RAGE signaling and
favors the accumulation of proinflammatory macrophages
(Yan et al., 1994; McPhillips et al., 2007). RageDker animals
lack in the mutual activation of the RAGE and TNF-a
pathways. Consequently, the kinetics in the shift of
macrophages from a proinflammatory to an anti-
inflammatory phenotype may be changed in the absence of
epidermal RAGE expression in favor of the anti-inflammatory
phenotype, which contributes to the rapid clearance of
apoptotic neutrophils. However, we could not detect a
RAGE-dependent difference in the occurrence of apoptotic
neutrophils, as only few TdT-mediated dNTP nick end
labeling-positive neutrophils were detectable (data not
shown), suggesting that the removal of apoptotic cells is
efficient in vivo. Consequently, the rapid clearance of
neutrophils and the lack of proinflammatory mediators
reduce the accumulation of macrophages in RageDker
animals. Altogether, the kinetics of the inflammatory
response is condensed to a shorter time frame. The
perpetuated epidermal expression of TNF-a in control
animals is in line with the inhibition of immune resolution
as discussed above and the prolonged expression of Keratin 6.
Our data suggest that RAGE expression in keratinocytes
contributes to a cytokine milieu that inhibits immune
resolution and favors perpetuated inflammation.
Consequently, keratinocyte-specific RAGE deletion allows
for an earlier switch from the establishment of an inflamma-
tory reaction to the resolution phase. Unfortunately, the
complex paracrine interaction between keratinocytes and
the dermal compartment in vivo hampers the recapitulation
in vitro, and thus a deeper mechanistic analysis remains a
challenge and requires further experimental studies in the
future. As an example, TPA treatment of normal human
epidermal keratinocytes revealed a rapid but transient induc-
tion of the TNF-a transcript levels, which was not affected by a
RAGE antagonistic peptide (Arumugam et al., 2012 data not
shown). This suggests that in vitro monoculture models lack
additional stimuli for maintaining TNF-a transcript levels in a
RAGE-dependent manner. However, our observations fit well
into the model that RAGE modulates and sustains reactions
that were initiated by other sources (Schmidt et al., 2001;
Bopp et al., 2008; Ramasamy et al., 2011).
In summary, the results presented here increase our
knowledge on RAGE-dependent regulation of skin inflam-
mation. Whereas other models focused on the systemic
effect of RAGE inhibition by genetic deletion or pharmaco-
logical inhibition, our studies identify an immune-modula-
tory function of RAGE in skin, which can be clearly
attributed to a specific cell type of the epidermis. Our data
suggest that RAGE deletion in keratinocytes leads to a
premature resolution of skin inflammation, which is at least
in part dependent on its impact on the kinetics of TNF-a
expression in keratinocytes. In consequence, therapeutic
targeting of RAGE may be exploited for the development
of new drugs in the topical treatment of inflammatory skin
diseases, which circumvents potential adverse effects
through systemic immune suppression.
MATERIALS AND METHODS
Animal work and sample preparation
Animals were maintained in a specific pathogen-free environment in
the animal facility of the German Cancer Research Center and all
experiments were reviewed and approved by the governmental
committee for animal experimentation. Mice carrying a keratino-
cyte-specific deletion of RAGE (RageDker) were generated by breeding
Rageflx animals (Liliensiek et al., 2004) with K14-Cre animals
(Huelsken et al., 2001). Primers used for genotyping PCR are listed
in Supplementary Table S1 online. Seven-week-old female mice were
treated with 10 nmol TPA (Sigma, Munich, Germany) in 100ml
acetone on to the shaved back skin and mice were killed at indicated
time points by inhalation of carbon dioxide and cervical dislocation.
Samples for laser microdissection were snap frozen in liquid nitrogen.
For histology, tissues were fixed with 4% paraformaldehyde in PBS,
pH 7.4, embedded in paraffin, and cut into 6mm-thick sections
(Gebhardt et al., 2008).
Immunohistochemistry analysis
Antigens were retrieved by digestion with proteinase K (Sigma) or
boiling in citrate buffer before incubation with anti-Gr-1 (RB6-8C5,
eBioscience, Frankfurt, Germany) or anti-S100a9 (M-19, Santa Cruz,
Heidelberg, Germany), respectively. Biotinylated secondary antibo-
dies were purchased from Vector Laboratories, Lo¨rrach, Germany.
Staining patterns were developed using the Vectastain Elite ABC Kit
(Vector Laboratories) and AECþ Substrate Chromogen (Dako, Ham-
burg, Germany). All tissue sections were counterstained with hema-
toxylin (AppliChem, Darmstadt, Germany).
Immunofluorescence analysis
Antigens were retrieved by boiling in citrate buffer. Antibodies were
anti-Keratin 6 (Covance, Munich, Germany), anti-GFP (1:200, Abcam,
Cambridge, UK), anti-rabbit-Cy3 (Dianova, Hamburg, Germany), and
anti-chicken-TxRed (kindly provided by Prof. Dr Zentgraf, DKFZ
Heidelberg). All tissue sections were counterstained with H33324
(Calbiochem Merck, Darmstadt, Germany)
Isolation and analysis of leukocytes from back skin
Skin tissue was digested with 2 mg ml 1 collagenase IV (Sigma) in
DMEM supplemented with 10mg ml 1 DNaseI (Genaxxon, Ulm,
Germany) and 2% fetal calf serum (Sigma) at 37 1C for 1 hour.
Digestion was stopped with PBS/EDTA and tissue pieces were forced
through a 40-mm cell strainer. Following blocking of Fc receptors by
anti-CD16/32 (eBioscience), cells were stained with F4/80-PE
(eBioscience), Ly6g-FITC, CD11b-APC (BD, Heidelberg, Germany),
CD45-APC:Cy7, and Ly6c-PerCP:Cy5.5 (Biolegend, Fell, Germany).
Dead cells were stained with H33342 (Calbiochem Merck) directly
before analysis with the LSRII flow cytometer (BD). Total cell numbers
were determined using BD TruCount tubes (BD). Data were analyzed
using FlowJo (Treestar, Oregon, Ashland).
Laser microdissection
Frozen tissue samples were cut in 14mm section, fixed in 70%
ethanol, and stained in 1% cresyl violet solution (Sigma). Slides were
dipped in 70% ethanol, 100% ethanol and acetone, dried at room
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temperature, and stored at  80 1C in air-tight containers. Stained
slides were mounted onto a P.A.L.M. Microbeam (Zeiss, Munich,
Germany) and interfollicular epidermis was collected contact free in
adhesive caps (Zeiss) using the CloseCut-AutoLPC mode of the
P.A.L.M. Robo Software V4.0.2.13 (Zeiss).
RNA preparation and amplification
RNA was isolated using the RNeasy Micro Kit (Qiagen, Hilden,
Germany). RNA quantity and quality was determined with the help of
the RNA 6000 Pico Kit and the 2100 Bioanalyzer (Agilent Technologies,
Bo¨blingen, Germany). RNA was reverse transcribed and amplified using
the Ovation PicoSL WTA System V2 (NuGen, San Carlos, CA).
qRT–PCR analysis
qRT–PCR was performed using the Power SYBR Green PCR Master
Mix and the StepOnePlus real-time PCR system (Applied Biosystems,
Carlsbad, CA). Relative expression of a gene of interest was
determined using the DCt method and expression was normalized
using three house-keeping genes. Primers are listed in Supplementary
Table S1 online.
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